Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
17.6M
-
Shares change
-
+3.97M
-
Total reported value, excl. options
-
$616M
-
Value change
-
+$141M
-
Number of buys
-
54
-
Number of sells
-
-16
-
Price
-
$34.95
Significant Holders of ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) as of Q3 2017
75 filings reported holding ANAB - ANAPTYSBIO, INC - Common Stock, par value $0.001 per share as of Q3 2017.
ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.6M shares
of 28M outstanding shares and own 63% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (3.69M shares), FMR LLC (2.19M shares), BVF INC/IL (1.38M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.22M shares), Novo Holdings A/S (1.19M shares), Cormorant Asset Management, LLC (1M shares), PERCEPTIVE ADVISORS LLC (982K shares), DEERFIELD MANAGEMENT CO (824K shares), BlackRock Inc. (683K shares), and CITADEL ADVISORS LLC (584K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.